In a regulatory filing, Mirum Pharmaceuticals disclosed that its CFO Ian Clements bought 1,592 shares of common stock in a transaction size of $27K, boosting his stake by 25%.

This is the 4th consecutive decrease in holdings and the lowest level since May 1st, 2020.

Volaris reports Februay 2021 preliminary traffic results. In February 2021, capacity measured by ASMs, or Available Seat Miles, was 74.7% compared to the same month of the prior year. Demand measured by RPMs, or Revenue Passenger Miles, was65% of the prior year. Volaris transported 1.1 million passengers in February 2021 and booked load factor was % 74.1% vs. 85.1% last year. While management is using 2020 for its February 2021 comparisons, it should be noted that the COVID-19 pandemic did not start to impact demand in Mexico until the second half of March 2020.

"Casey's grew diluted earnings per share in the third quarter despite a challenging, COVID-19 impacted environment," said Darren Rebelez, President and CEO. "The company advanced several initiatives in our grocery and other merchandise category that contributed to positive inside sales volume in the quarter and investment in our fuel capabilities yielded favorable results. We continue to effectively manage discretionary operating expenses while investing in our team members' and guests' safety. Our balance sheet remains strong, and we are committed to executing our long-term strategic plan."

Q3 fuel gross profit increased 37% with a fuel margin of 32.9c per gallon.

India Globalization Capital announced that on March 2, the company received one more patent (patent#10,933,082) from the United States Patent and Trademark Office for the company's cannabinoid composition and method for treating pain in patients with Psoriatic Arthritis, Fibromyalgia, Scleroderma and other conditions. The patent application was filed on October 1, 2018. The latest patent approval adds to the company's existing patent portfolio, which includes patent issuances by the USPTO for seizure disorders and eating disorders.